A Multicenter, Double Blinded, Randomized, Parallel Assignment Study to Demonstrate the Efficacy of DA9601
PHASE4CompletedINTERVENTIONAL
Enrollment
520
Participants
Timeline
Start Date
September 30, 2012
Primary Completion Date
March 31, 2014
Study Completion Date
March 31, 2014
Conditions
NSAID-associated Gastroduodenal Injury
Interventions
DRUG
Stillen
DRUG
Cytotec (reference drug)
DRUG
NSAID (Aceclofenac)
Trial Locations (1)
614735
Inje University Busan Paik Hospital, Busan
All Listed Sponsors
lead
Dong-A ST Co., Ltd.
INDUSTRY
NCT01912066 - A Multicenter, Double Blinded, Randomized, Parallel Assignment Study to Demonstrate the Efficacy of DA9601 | Biotech Hunter | Biotech Hunter